CytomX Therapeutics (CTMX) Capital Expenditures (QoQ) (2015 - 2025)
CytomX Therapeutics (CTMX) Capital Expenditures (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 258.27% |
| Sep 30, 2025 | -570.37% |
| Jun 30, 2025 | -77.31% |
| Mar 31, 2025 | 48.75% |
| Dec 31, 2024 | 321.05% |
| Sep 30, 2024 | -80.21% |
| Jun 30, 2024 | -16.52% |
| Mar 31, 2024 | 123.05% |
| Dec 31, 2023 | -5,644.44% |
| Sep 30, 2023 | -98.26% |
| Jun 30, 2023 | 977.08% |
| Mar 31, 2023 | -73.63% |
| Dec 31, 2022 | -55.61% |
| Sep 30, 2022 | -0.49% |
| Jun 30, 2022 | -44.02% |
| Mar 31, 2022 | 200.41% |
| Dec 31, 2021 | -8.58% |
| Sep 30, 2021 | 135.09% |
| Jun 30, 2021 | -88.39% |
| Mar 31, 2021 | 156.37% |